ArticleMayo Clinic proceedings. Innovations, quality & outcomes2022

Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.

Deblina Raychaudhuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.